Calafiore Massimo 4
4 · Orthofix Medical Inc. · Filed Mar 6, 2026
Research Summary
AI-generated summary of this filing
Orthofix Medical (OFIX) CEO Massimo Calafiore Sells Shares
What Happened
Massimo Calafiore, President & CEO and a director of Orthofix Medical (OFIX), disposed of 12,220 shares in two open-market transactions: 6,189 shares on 2026-03-04 at a weighted average price of $12.92 (proceeds $79,939) and 6,031 shares on 2026-03-05 at a weighted average price of $12.55 (proceeds $75,694). Total proceeds were about $155,633. These sales were made to satisfy tax-withholding obligations related to the settlement of restricted stock units (RSUs), not reported as discretionary trades by the insider.
Key Details
- Transaction dates and prices:
- 2026-03-04: 6,189 shares sold, weighted avg price $12.92 (range $12.80–$13.03 per footnote)
- 2026-03-05: 6,031 shares sold, weighted avg price $12.55 (range $12.48–$12.72 per footnote)
- Total shares sold: 12,220; total proceeds ≈ $155,633.
- Shares owned after transaction: not explicitly stated in the provided summary; filing notes include 221,042 previously reported RSUs (footnote F3).
- Footnotes:
- F1: Sales were to satisfy tax withholding on RSU settlement via a pre-existing, mandatory sell-to-cover arrangement approved by the Compensation and Talent Development Committee; sales made without the reporting person’s discretion.
- F2/F4: Reported prices are weighted averages; multiple execution prices within the stated ranges.
- Filing timeliness: Form 4 filed 2026-03-06 for transactions on 2026-03-04 and 2026-03-05; appears to be filed within the usual Form 4 reporting window.
Context
These were sell-to-cover tax-withholding sales tied to RSU settlement (routine administrative transactions), which are generally not read as an indicator of the insider’s market view. No option exercises, gifts, or discretionary open-market selling were reported.
Insider Transaction Report
- Sale
Common Stock
[F1][F2][F3]2026-03-04$12.92/sh−6,189$79,939→ 326,167 total - Sale
Common Stock
[F1][F4][F3]2026-03-05$12.55/sh−6,031$75,694→ 320,136 total
Footnotes (4)
- [F1]Represents the number of shares of common stock sold to satisfy tax withholding obligations in connection with the settlement of restricted stock units, pursuant to a pre-existing sell-to-cover requirement previously approved and mandated by the Compensation and Talent Development Committee of the Company's Board of Directors (the administrator of the plan pursuant to which such restricted stock units were granted). Such sale was made without the exercise of any discretion by the reporting person.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.80 to $13.03, inclusive. The reporting person undertakes to provide to Orthofix Medical Inc., any security holder of Orthofix Medical Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (4) to this Form 4.
- [F3]Includes 221,042 previously reported restricted stock units.
- [F4]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.48 to $12.72, inclusive.